GlobeNewswire by notified

Ensurge starts manufacturing scale-up and commercialization of the world’s first high energy density rechargeable solid-state microbatteries

Share

SAN JOSE, Calif., May 22, 2023 - Ensurge Micropower (OSE: ENSU, and OTCIQ: ENMPY), a leading provider of solid-state lithium microbatteries for a new generation of wearables, hearables and IoT devices, today announced it is reliably producing packaged lithium solid-state microbatteries with high performance and improved manufacturing flow. In addition to this progress, Ensurge has started producing sample volumes of high capacity multi-layer solid-state lithium microbatteriesusing its innovative and unique architecture based on a 10-micron stainless steel substrate. Achieving these industry-first milestones is a major step toward bringing Ensurge's  solid-state microbattery products into volume production, now projected for the second half of the year.

“These two milestones are extremely significant for Ensurge as it prepares to scale production for these market-changing solid-state lithium microbatteries.  Our batteries will revolutionize the way next generation products are designed to enable enhanced capabilities and performance,” said Mark Newman, Ensurge Chief Executive Officer. “The Ensurge technical and operations teams have done a phenomenal job in making substantial progress over the last six (6) months to realize the world’s first high energy density microbatteries with capacities in the 1 to 100 milliampere-hour range (mAh).”

Ensurge’s solid-state lithium microbatteries provide Volumetric Energy Density (VED) of 650 to 750 Watt-hours per liter (Wh/L) that is as much as three times that of similar capacity Lithium-ion (Li-ion) microbatteries and up to ten times that of competing solid-state microbatteries. This VED breakthrough enables Ensurge microbatteries to pack more capacity in a small form factor that is also customizable to suit the shape of the end-product. Beyond their VED advancements, these solid-state lithium microbatteries also provide other benefits including charging to 80% battery capacity in 20 minutes compared to Li-ion microbatteries, which need up to 2 hours to be recharged. Also, Ensurge microbatteries support higher discharge pulses of at least 5C, enabling them to support many wireless communication chipsets or other current load transients as hearable and wearable users demand improved connectivity. Additionally, the ability for the microbattieries to be assembled using a standard Surface Mount Technology (SMT) process reduces manufacturing costs while increasing production output. 

Ensurge is simultaneously preparing to scale production of a customized version of its microbattery that it has developed for an innovator in the digital health market. This customer placed a 150,000-unit order for the product in December 2022. 

Over the past 10 months, Ensurge has made steady progress toward bringing its microbattery to market, including shipping unit-cell samples and then packaged microbattery samples to multiple prospective customers and strategic partners. Through these development stages, the company has validated key elements of its solid-state lithium microbattery chemistry and packaging that will enable hearable and wearable suppliers to create products with features that cannot be offered using alternative battery technology.

For more information about Ensurge's microbattery technology visit the company's website at www.ensurge.com

About Ensurge Micropower

Ensurge is Energizing Innovation™ with the first ultrathin, flexible, reliable, and fundamentally safe solid-state lithium microbattery for the 1 to 100 milliampere-hour (mAh) class of wearable devices, connected sensors, and beyond. The innovative Ensurge Microbattery enables energy-dense rechargeable products that are ideal for form-factor-constrained applications including hearables (hearing aids and wireless headphones), digital and health wearables, sports and fitness devices, and IoT sensor solutions that use energy harvesting to power everyday things. The company's state-of-the-art manufacturing facility, located in the heart of Silicon Valley, combines patented process technology and materials innovation with the scale of roll-to-roll production methods to bring the advantages of Ensurge technology to established and expanding markets.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Contact 

Mark Newman - Chief Executive Officer 
E-mail: mark.newman@ensurge.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Første uge i tilbudsperioden i Jobindex A/S10.6.2023 12:00:37 CEST | pressemeddelelse

Danielsen 2 aps - der er hovedaktionær i Jobindex A/S - har den 2. juni 2023 fremsat et frivilligt ureguleret offentligt købstilbud om at købe aktier i Jobindex A/S til en pris på 1900 kr. pr. aktie i forbindelse med ansøgning om afnotering fra First North. På tilbudsperiodens tredje og fjerde dag har Danielsen 2 aps købt 1212 og 944 aktier á 1900 kr. pr. aktie. Den første uge har Danielsen 2 aps i alt købt 4645 aktier. Tilbudsperioden fortsætter indtil den 30. juni 2023. Det forventes at Jobindex A/S derefter vil blive afnoteret og slettet fra handel på Nasdaq First North i henhold til punkt 2.6(c)(i) i Supplement D i Nasdaqs regler. Yderligere oplysninger Direktør Kaare Danielsen, telefon 20735010, email kd@jobindex.dk Certified Adviser Jakob Tolstrup Kristensen, email jakob.tolstrup@cwicf.com Vedhæftet fil Aktiehandel tilbud 2023 juni 9

PRIX FITZGERALD 2023 LAUREATE ANNOUNCED AT HÔTEL BELLES RIVES10.6.2023 01:03:24 CEST | Press release

Quentin Tarantino Accepts 12th Annual Literary Award for Cinema Speculation CAP D’ANTIBES, France, June 09, 2023 (GLOBE NEWSWIRE) -- During an unforgettable ceremony held this evening Hôtel Belles Rives in Juan-les-Pins on the French Riviera, jury members of the 2023 Prix Fitzgerald, a French literary award created in 2011 by Marianne Estène-Chauvin, President of the Francis Scott Fitzgerald Academy and owner of Belles Rives Group, announced today this year’s laureate. The long-awaited first work of nonfiction from the author of the #1 New York Times bestselling Once Upon a Time in Hollywood, Quentin Tarantino accepted the prize for Cinema Speculation, published by HarperCollins in the United States and Weidenfeld & Nicolson in the United Kingdom on November 1, 2022 and French publishing house, Flammarion on March 22, 2023. Every year in June, the Hôtel Belles Rives hosts the Prix Fitzgerald, which honors a novel or short story that reflects the elegance, spirit, and art of living embo

FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease10.6.2023 00:45:00 CEST | Press release

Peripheral and Central Nervous System Drugs Advisory Committee votedbased on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer’s disease The PDUFA action date for traditional approval of LEQEMBI has been set for July 6, 2023, with designation of priority review LEQEMBI received accelerated approval from the FDA for the treatment of early Alzheimer’s disease on January 6, 2023 TOKYO and CAMBRIDGE, Mass., June 09, 2023 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted unanimously that the data from Eisai’s Phase 3 Clarity AD clinical trial confirms the clinical benefit of LEQEMBI® (lecanemab-irmb) 100 mg/mL injection for intravenous

Travel Startup Yovivo Expands Core Team With New Staff Members9.6.2023 20:47:00 CEST | Press release

Extended stays booking site hires Karen Kochmann (Ex-Expedia) and Erik Beekman (Ex Savills) to keep up with its fast expansion ROTTERDAM, Netherlands, June 09, 2023 (GLOBE NEWSWIRE) -- Growing startup Yovivo.com today announced its latest team expansion with the addition of two key members from the travel and real estate industries. Karen Kochmann has been taken on by Yovivo in the position of Strategic Growth Manager. Formerly Expedia’s Account Manager for the Balearic Islands (where the Yovivo offices and team are located), Karen boasts over seven years of experience, a masters degree in Digital Marketing and E-commerce, and a Banking degree from Lauder Business School. “I plan to developing strategic partnerships which will help Yovivo grow and position itself as a leading brand for extended stays. With my experience in the field of tech and tourism I will be able to bring fresh ideas to both the development of the platform and the B2C and B2B approach planned. I'll also focus on cr

Nokia Corporation: Repurchase of own shares on 09.06.20239.6.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 9 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 09.06.2023 Espoo, Finland – On 9 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL323,9103.77CEUX33,5313.77AQEU1,0683.77TQEX14,9913.77Total373,5003.77 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 and e